Proportion of patients with controlled (<5.0) and uncontrolled (≥5.0) levels of TC (mmol/L) throughout the study in both subgroups: post hoc analysis
| Lipid-lowering drug treatment (n=766) | Baseline | 12 weeks | 24 weeks |
| TC<5.0 mmol/L | 23 (3.0) | 86 (11.2) | 279 (36.4) |
| TC≥5.0 mmol/L | 740 (96.6) | 660 (86.2) | 480 (62.7) |
| Unavailable data | 3 (0.4) | 20 (2.6) | 7 (0.9) |
| No lipid-lowering drug treatment (n=2077) | Baseline | 12 weeks | 24 weeks |
| TC<5.0 mmol/L | 370 (17.8) | 482 (23.2) | 691 (33.3) |
| TC≥5.0 mmol/L | 1653 (79.6) | 1387 (66.8) | 1240 (59.7) |
| Unavailable data | 54 (2.6) | 208 (10.0) | 146 (7.0) |
Data are expressed as n (%). Percentages are calculated as n/N.
TC, total cholesterol.